Navigation Links
Innovative Partnership Helps Improve Medical Research by Optimizing Clinical Trials
Date:7/20/2010

NEW YORK, July 20 /PRNewswire/ -- Target Health Inc. and LifeOnKey, Inc. today announced they have joined forces to offer an innovative, web-based information platform that will allow the bio-pharmaceutical and medical device industries to optimize clinical trials, help researchers capture, analyze and assess trial data more efficiently, and bring innovative new medicines and devices to patients. 

Through its partnership with LifeOnKey, Target Health can provide health care companies with an electronic clinical trial record that can manage and monitor the care of clinical trial patients from Phase I through Phase IV post-marketing surveillance.  

By combining Target Health's clinical trial software with LifeOnKey's electronic health records (EHRs), the partnership will give clinicians online access to the most recent medical information for their clinical trial patients, allowing them to efficiently track critical information – from side effects to health improvements, while maintaining the integrity of the clinical trial data.  Meanwhile, patients will gain the ability to follow the progress of the clinical trial through their own patient health record.  

"We are very enthusiastic about building a comprehensive solution that integrates clinical trial software and EHRs – the first offering of its kind for this industry," said Target Health President Dr. Jules Mitchel. "This partnership leverages the deep expertise with clinical trials and information systems within both companies to enhance the efficiency of the drug, biologic and device development process."  

"This partnership clearly highlights the ultimate promise of health information technology," said Dr. Linda Harnevo, CEO of LifeOnKey.  "Through the smart application of information technology, we can help clinicians improve the clinical trial process from end-to-end – from better patient recruitment to more effective patient monitoring once the drug is on the market."  

According to Dr. Mitchel and Dr. Harnevo, the Target Health-LifeOnKey partnership will also ensure better compliance with clinical trial requirements and help medical researchers track specific patient groups, follow product use and evaluate patient outcomes over the long term.

About Target Health Inc.

Target Health, established in 1993, is a full-service eCRO with full-time staff dedicated to all aspects of drug and device development. Areas of expertise include Regulatory Affairs, comprising, but not limited to, strategic planning, IND, IDE, eCTD NDA, PMA and 510(k) submissions, Clinical Trial Monitoring and Project Management, Biostatistics, Data Management, EDC utilizing Target e*CRF®, and Medical Writing. Target Health has developed a full suite of eClinical Trial software including Target e*CRF® (EDC plus randomization and batch edit checks); Target e*CTMS™; Target Document®; (paperless TMF and beyond); Target Encoder® (for MedDRA and WHO Drug); and Target Newsletter®.  Target Health's Pharmaceutical Advisory Dream Team assists companies in strategic planning from Discovery to Market Launch.

www.targethealth.com

About LifeOnKey, Inc.

LifeOnKey is a leader in personalized health technology solutions.  LifeOnKey transforms the way health information is collected, managed and analyzed by major health care stakeholders and used by individuals to improve wellness and self-care.  LifeOnKey's three primary applications – an electronic health record (EHR), a personal health record (PHR) and a Research Center – are seamlessly integrated, delivering relevant data that can be targeted to the needs of each unique user.  The company currently has 1.5 million patient users globally.  LifeOnKey's headquarters are located in New York and its R&D in Herzliya, Israel.

www.lifeonkey.com


'/>"/>
SOURCE Target Health Inc.; LifeOnKey, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Havels Incorporated Announces the Release of Four New Innovative Ultrasound Needles
2. US Patent Allowed for Spring Action That Separates Protectus Innovative Safety Syringe From All Others
3. OvaGene Oncology Opens New Innovative Gynecologic Cancer Laboratory and Research Facility
4. PolyTouch Medical Ltd. Receives FDA Clearance to Commercialize PatchAssist(TM) - an Innovative Surgical Instrument Intended to Facilitate the Delivery of Soft Tissue Prosthetics During the Laparoscopic Repair of Soft Tissue Defects
5. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
6. Seventh Annual Healthcare Unbound Conference Features Innovative Applications of Remote Monitoring, Home Telehealth, mHealth, Social Media and eHealth to Manage Diseases and Promote Wellness
7. Tibotec Therapeutics Debuts Innovative Web Portal for HIV/AIDS Front-Line Service Providers
8. DNA Medicine Institute Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
9. Henry Schein Announces the Launch of Innovative Henry Schein ConnectHealth(TM) Collaborative
10. I3, the Developer of Innovative Infusion Therapy Solutions, to Present at Medtech Insight In3 Conference in Las Vegas, March 4-5, 2010
11. Innovative University of Cincinnati Program Trains Next Generation of Pharmaceutical Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... BRUSSELS , Dec. 2, 2016  UCB is pleased to ... presentation at the upcoming 70 th American Epilepsy Society ... Houston, TX , USA. 1-12 ... safety and efficacy profile of VIMPAT ® (lacosamide) CV ... also share findings on the current state of the union ...
(Date:12/2/2016)... Dec. 2, 2016 Allergan plc (NYSE: ... information on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a ... the Company will repurchase $10 billion of its ordinary shares. ...
Breaking Medicine Technology:
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, ... while maintaining fulfilling lives. “We are prolonging life 6 years in the last ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):